• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

EndoSonics wins clearance for Trak Back

Article

Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus

Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus facilitating both 3-D-like images and cross-sectional displays. Trak Back was designed for use with EndoSonics’s Oracle ultrasound systems and Visions Five-64 series of ultrasound catheters.

The device is automated, which the Rancho Cordova, CA, company believes will make it easier to use than competitive IVUS products that are mechanical. Trak Back is part of EndoSonics’s strategy to provide its customers with IVUS-guided stenting products by combining its catheters with therapeutic devices. EndoSonics expects to begin shipping Trak Back by the end of the third quarter 1999.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.